Skip to main content
Premium Trial:

Request an Annual Quote

Money and the Prize

Russian billionaire Alisher Usmanov, who bought James Watson's Nobel Prize at auction last week for more than $4 million, says he wants Watson to keep it, NPR reports.

Usmanov is thought to be worth some $15 billion — he holds assets in steel and mining and is a major stakeholder in the Arsenal football club, the Guardian adds.

In a statement, Usmanov says that "a situation in which an outstanding scientist has to sell a medal recognizing his achievements is unacceptable." He notes that Watson's work has contributed to cancer research, a disease that has affected his family.

"It is important for me that the money that I spent on this medal will go to supporting scientific research, and the medal will stay with the person who deserved it," he adds.

Watson, who won the Nobel Prize in 1962 with Francis Crick and Maurice Wilkins for determining the structure of DNA, had said he was selling the prize out of both financial necessity and to raise money for charity and research.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more